Biomark Receives Approval For Its Lung Cancer Treatment Protocol
Press Release – BUX – Expansion of Cancer Platform (PDF) ———————————————
BioMark Closes First Tranche Of Private Placement Offering
Press Release – Biomark Closes Partial Private Placement-March 15th 2016 (PDF) ———————————————
A Good Choice for MMJ and Biotech Market Opportunity

A Good Choice for MMJ and Biotech Market Opportunity Gaalen Engen, Stockhouse.com Original article: http://www.stockhouse.com/news/newswire/2016/03/03/a-good-choice-for-mmj-and-biotech-market-opportunity For almost fifty years, his was a trusted voice when it came to sports and news. Bill Good, following in the footsteps of his father, “Breathless Bill”, established himself as a national broadcasting icon over a long career which included […]
World Cancer Day – Message of Hope

World Cancer Day – Message of Hope
Dr James Bond on Biomark

Dr James Bond on Biomark
BioMark Announces Progress Towards Data Analysis
BioMark Announce Progress Towards Data Analysis (PDF) ———————————————
BioMark CEO Interview with SNNLive, Sep 2015

Stock News Now Interview In this SNNLive On-Location, our host spoke with Rashid Ahmed, President and CEO of BioMark Diagnostics Inc. (OTCQB: BMKDF) in New York City, NY.
BioMark Diagnostics presents at Rodman & Renshaw Conference in NY, USA

BioMark Diagnostics Inc. presents at Rodman & Reshaw Conference in New York, USA Follow these links for our audio presentation and corporate overview power point. Audio Presentation Powerpoint Presentation
BioMark AGM
BioMark is holding its Annual General and Special Meeting on September 17, 2015 at 925 W Georgia Street #1820, Vancouver, BC. We look forward to seeing you at the meeting. For more information, please visit SEDAR DOWNLOAD AGM MATERIALS FORM OF PROXY (PDF) NOTICE OF MEETING (PDF) MANAGEMENT INFORMATION CIRCULAR (PDF)
BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator
BioMark Diagnostics to Conduct Validation Studies (PDF) ———————————————